ASCO pushes more HPV vaccine use in published recommendations
The American Society of Clinical Oncologists has released recommendations to boost the severely low rate of HPV vaccination in the United States.
Immunovaccine pairs with security firm Leidos on Zika work
Nova Scotia's Immunovaccine and national security contractor Leidos hope their Zika vaccine approach can speed vaccine development during disease…
Pfizer to 'spotlight' vaccines following Allergan bust, firm predicts
Market research firm Kalorama predicts Pfizer will continue to lean on its burgeoning vax unit in the wake of the collapse of the Allergan megamerger.
Kaketsuken in talks with Astellas to sell its vaccines business
While much of the world is focused on the explosive Zika outbreak, a similar virus is spreading in in Angola with lethal consequences.
The NIH is committing millions in research funding to better understand adjuvant combinations as part of a push to promote adjuvant discovery and development.
In a frantic effort to curb the Zika outbreak, world vaccines experts are pooling knowledge to hopefully inform vaccine development.
When Genocea unveiled its genital herpes vaccine, it aimed to develop a therapeutic vaccine for the disease and compete with daily oral antivirals.
A University of California, Irvine, team won $8 million from the DOD's Defense Threat Reduction Agency to develop a new vaccine against Q fever.
A team at the University of Texas Medical Branch has developed a mouse model to test Zika vaccines and treatments after three weeks, cutting down the usual…